Abstract:Small extracellular vesicles (sEVs) have gained wide attention as efficient carriers for disease treatment. However, the proclivity of sEVs to be ingested by source cells is insufficient to accurately target specific sites, posing a challenge in realizing controlled targeting treatment. Here, we developed an engineered sEV nanocarrier capable of precise tumor targeting and enhanced synergistic therapy. Multivalent DNA probes, comprising abundant AS1411 aptamers and telomerase primers, were innovatively modified on the sEV membrane (M-D-sEV) for precise tumor targeting. To achieve synergistic therapy, gold nanorod-cerium oxide nanostructures (Au NRs-CeO2) and manganese dioxide nanosheets-doxorubicin (MnO2 NSs-DOX) were encapsulated into liposomes (Lip-Mat). Then M-D-sEV and Lip-Mat were fused together through membrane fusion to obtain nanocarriers. Owing to the multivalence of the probes, the surface of the nanocarriers was loaded with numerous aptamers, which greatly enhances their targeting ability and promotes the accumulation of drugs. When nanocarriers were ingested by tumor cells, telomerase and multivalent DNA probes triggered their aggregation, enhancing the therapeutic effect. Furthermore, under laser irradiation, Au NRs-CeO2 converted light into hyperthermia, thereby inducing the destruction of nanocarriers membrane. This process initiated a series of reactions involving glutathione and H2O2 consumption, as well as DOX release, ultimately achieving synergistic tumor therapy. In vitro and in vivo studies demonstrated the remarkable targeting ability of multivalent DNA probes and excellent therapeutic effect of this strategy. The engineered strategy of sEVs provide a promising approach for precise tumor therapy and hold great potential for the development of efficient, safe, and personalized drug delivery systems.

Engineered Cancer-Derived Small Extracellular Vesicle-Liposome Hybrid Delivery System for Targeted Treatment of Breast Cancer

Engineered Extracellular Vesicles for Cancer Therapy

Physio-chemical Modifications to Re-engineer Small Extracellular Vesicles for Targeted Anticancer Therapeutics Delivery and Imaging

Engineered extracellular vesicles: potentials in cancer combination therapy

An off-the-shelf small extracellular vesicle nanomedicine for tumor targeting therapy

Engineered extracellular vesicles and their mimetics for cancer immunotherapy

Engineered extracellular vesicles: A new approach for targeted therapy of tumors and overcoming drug resistance

Engineering small extracellular vesicles with multivalent DNA probes for precise tumor targeting and enhanced synergistic therapy

Recent Advancement and Technical Challenges in Developing Small Extracellular Vesicles for Cancer Drug Delivery

Engineered mesenchymal stem cell-derived extracellular vesicles constitute a versatile platform for targeted drug delivery

Small extracellular vesicle loading systems in cancer therapy: Current status and the way forward

Tumor cell-derived extracellular vesicles for breast cancer specific delivery of therapeutic P53

Extracellular Vesicles as Drug Delivery System for Cancer Therapy

New approaches in extracellular vesicle engineering for improving the efficacy of anti-cancer therapies

Extracellular vesicle-based drug delivery systems for cancer treatment

Extracellular Vesicles as an Advanced Delivery Biomaterial for Precision Cancer Immunotherapy

Application of engineered extracellular vesicles for targeted tumor therapy

Targeted Delivery of Exosomes Armed with Anti-Cancer Therapeutics

Extracellular Vesicles for Drug Delivery in Cancer Treatment

Engineered Extracellular Vesicles with Compound-Induced Cargo Delivery to Solid Tumors

Extracellular vesicles as drug vectors for precise cancer treatment.